Effects of atorvastatin on pharmacokinetics of amlodipine in rats and its potential mechanism

References

• Adake P, Somashekar HS, Mohammed Rafeeq PK, et al. (2015). Comparison of amlodipine with cilnidipine on antihypertensive efficacy and incidence of pedal edema in mild to moderate hypertensive individuals: a prospective study. J Adv Pharm Technol Res 6:81–5.
   PubMed Web of Science ®Google Scholar
• Agrawal H, Aggarwal K, Littrell R, et al. (2015). Pharmacological and non pharmacological strategies in the management of coronary artery disease and chronic kidney disease. Curr Cardiol Rev 11:261–9.
   PubMed Web of Science ®Google Scholar
• Choi DH, Chang KS, Hong SP, et al. (2008). Effect of atorvastatin on the intravenous and oral pharmacokinetics of verapamil in rats. Biopharm Drug Dispos 29:45–50.
   PubMed Web of Science ®Google Scholar
• Choi MS, Yu JS, Yoo HH, Kim DH. (2018). The role of gut microbiota in the pharmacokinetics of antihypertensive drugs. Pharmacol Res 130:164–71.
   PubMed Web of Science ®Google Scholar
• Clarke AT, Mills PR. (2006). Atorvastatin associated liver disease. Dig Liver Dis 38:772–7.
   PubMedGoogle Scholar
• Feldman L, Vinker S, Efrati S, et al. (2016). Amlodipine treatment of hypertension associates with a decreased dementia risk. Clin Exp Hypertens 38:545–9.
   PubMed Web of Science ®Google Scholar
• Han X, Zhang H, Hao H, et al. (2019). Effect Of epigallocatechin-3-gallate on the pharmacokinetics of amlodipine in rats. Xenobiotica 49:970–4.
   PubMed Web of Science ®Google Scholar
• Huang Y, Zhao J, Jian W, Wang G. (2017). Effects of verapamil on the pharmacokinetics of dihydromyricetin in rats and its potential mechanism. Xenobiotica 48:839–844.
   PubMed Web of Science ®Google Scholar
• Khodadoustan S, Nasri Ashrafi I, Vanaja Satheesh K, et al. (2017). Evaluation of the effect of time dependent dosing on pharmacokinetic and pharmacodynamics of amlodipine in normotensive and hypertensive human subjects. Clin Exp Hypertens 39:520–6.
   PubMed Web of Science ®Google Scholar
• Lee JE, van Heeswijk R, Alves K, et al. (2011). Effect of the hepatitis C virus protease inhibitor telaprevir on the pharmacokinetics of amlodipine and atorvastatin. Antimicrob Agents Chemother 55:4569–74.
   PubMed Web of Science ®Google Scholar
• Lennernäs H. (2003). Clinical pharmacokinetics of atorvastatin. Clin Pharmacokinet 42:1141–60.
   PubMed Web of Science ®Google Scholar
• Li H, Liu L, Xie L, et al. (2016). Effects of berberine on the pharmacokinetics of losartan and its metabolite EXP3174 in rats and its mechanism. Pharm Biol 54:2886–94.
   PubMed Web of Science ®Google Scholar
• Liang N, Yu X, Yu Q, et al. (2008). Effects of cyclosporine A and itraconazole on permeability, biliary excretion and pharmacokinetics of amlodipine. Drug Metab Lett 2:163–8.
   PubMedGoogle Scholar
• Liu L, Geng G, Sun S, et al. (2018). Effects of berberine on pharmacokinetics of amlodipine in rats and its potential mechanism. Lat Am J Pharm 37:1354–60.
   Web of Science ®Google Scholar
• Malhotra HS, Goa KL. (2001). Atorvastatin: an updated review of its pharmacological properties and use in dyslipidaemia. Drugs 61:1835–81.
   PubMed Web of Science ®Google Scholar
• Mannemala SS, Nagarajan JS. (2015). Development and validation of a HPLC-PDA bioanalytical method for the simultaneous estimation of Aliskiren and Amlodipine in human plasma. Biomed Chromatogr 29:346–52.
   PubMed Web of Science ®Google Scholar
• Mc Donnell CG, Shorten G, Van Pelt FN. (2005). Effect of atorvastatin and fluvastatin on the metabolism of midazolam by cytochrome P450 in vitro. Anaesthesia 60:747–53.
   PubMed Web of Science ®Google Scholar
• Naito T, Kubono N, Ishida T, et al. (2015). CYP3A activity based on plasma 4beta-hydroxycholesterol during the early postpartum period has an effect on the plasma disposition of amlodipine. Drug Metab Pharmacokinet 30:419–24.
   PubMed Web of Science ®Google Scholar
• Oh M, Park SE, Ghim JL, et al. (2017). Comparative pharmacokinetics of a fixed-dose combination vs concomitant administration of telmisartan and S-amlodipine in healthy adult volunteers. Drug Des Devel Ther 11:3543–50.
   PubMed Web of Science ®Google Scholar
• Ryu SH, Kim JW, Kim YS, Lee SH, et al. (2014). Negligible pharmacokinetic interaction of red ginseng and antihypertensive agent amlodipine in Sprague-Dawley rats. J Toxicol Environ Health A 77:1372–83.
   PubMed Web of Science ®Google Scholar
• Sirenko Y, Radchenko G. (2017). Impact of statin therapy on the blood pressure-lowering efficacy of a single-pill perindopril/amlodipine combination in hypertensive patients with hypercholesterolemia. High Blood Press Cardiovasc Prev 24:85–93.
   PubMed Web of Science ®Google Scholar
• Wang R, Zhang H, Sun S, et al. (2016a). Effect of ginkgo leaf tablets on the pharmacokinetics of amlodipine in rats. Eur J Drug Metab Pharmacokinet 41:825–33.
   PubMed Web of Science ®Google Scholar
• Wang S, Ouyang B, Aa J, et al. (2016b). Pharmacokinetics and tissue distribution of ginkgolide A, ginkgolide B, and ginkgolide K after intravenous infusion of ginkgo diterpene lactones in a rat model. J Pharm Biomed Anal 126:109–16.
   PubMed Web of Science ®Google Scholar
• Yoo HH, Kim IS, Yoo DH, Kim DH. (2016). Effects of orally administered antibiotics on the bioavailability of amlodipine: gut microbiota-mediated drug interaction. J Hypertens 34:156–62.
   PubMed Web of Science ®Google Scholar
• Zhang C, Gao Z, Niu L, Chen X. (2018). Effects of triptolide on pharmacokinetics of amlodipine in rats by using LC-MS/MS. Pharm Biol 56:132–7.
   PubMed Web of Science ®Google Scholar
• Zhang H, Han X, Li Y, et al. (2019). Effects of Danshen tablets on pharmacokinetics of amlodipine in rats. Pharm Biol 57:306–9.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Wang F, Li Q, et al. (2014). Amlodipine metabolism in human liver microsomes and roles of CYP3A4/5 in the dihydropyridine dehydrogenation. Drug Metab Dispos 42:245–9.
   PubMed Web of Science ®Google Scholar